| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |